Skip to main content
. 2023 Feb 6;48(3):528–538. doi: 10.1007/s10900-023-01198-5

Table 3.

Sample Description, Support for HPV Vaccine Requirements in Middle School, and Bivariate Associations with Support for HPV Vaccine Requirements in Middle School

Support for HPV Vaccine Requirements, n (%) Bivariate Association, OR [95% CI]
Total Agree (n = 242 43.1) Unsure (n = 156 27.8) Disagree
(n = 163 29.1)
Agree vs. Disagree Unsure vs. Disagree
Child Race/Ethnicity
Minority 130 (23.2) 60 (46.2) 41(31.5) 29 (22.3) Ref Ref
Non-Hispanic White 419 (74.5) 175 (41.8) 114 (27.2) 130 (31.0) 0.65 (0.40, 1.07) 0.62 (0.36, 1.06)
Child Sex
Female 278 (50.5) 118 (42.5) 79 (28.4) 81 (29.1) Ref Ref
Male 272 (49.5) 113 (41.5) 77 (28.3) 82 (30.2) 1.28 (0.71, 2.33) 1.04 (0.47, 2.31)
Parent Race/Ethnicity
Minority 109 (19.7) 55 (50.4) 32 (29.4) 22 (20.2) Ref Ref
White 445 (80.3) 183 (41.1) 123 (27.7) 139 (31.2) 0.53* [0.31, 0.91] 0.61 [0.34, 1.10]
Parent Biological Sex
Female 420 (74.9) 179 (42.6) 109 (26.0) 132 (31.4) Ref Ref
Male 141 (25.1) 63 (44.7) 47 (33.3) 31 (22.0) 1.5 [0.92, 2.44] 1.84 * [1.09, 3.09]
Parent Education
Bachelors or higher 200 (36.3) 91 (45.5) 60 (30.0) 49 (24.5) Ref Ref
Some college of less 351 (63.7) 146 (41.6) 94 (26.8) 111 (31.6) 0.71 [0.46, 1.08] 0.69 [0.43, 1.10]
Geography
Urban 211 (38.4) 98 (46.5) 56 (26.5) 57 (27.0) Ref Ref
Rural 339 (61.6) 139 (41.0) 98 (28.9) 102 (30.1) 0.79 [0.52, 1.19] 0.99 [0.62, 1.57]
Political Ideology
Conservative 166 (35.0) 64 (38.6) 46 (27.7) 56 (33.7) Ref Ref
Liberal 193 (40.7) 84 (43.5) 56 (29.0) 53 (27.5) 1.41 [0.73, 2.7] 1.29 [0.75, 2.21]
Moderate 115 (24.3) 59 (51.3) 30 (26.1) 26 (22.6) 1.99 * [1.11, 3.56] 1.39 [0.84, 2.28]
Healthcare Characteristics
Child HPV Shots
1+ 306 (54.7) 162 (52.9) 84 (27.5) 60 (19.6) Ref Ref
0 253 (45.3) 78 (30.8) 72 (28.5) 103 (40.7) 0.20 *** [0.13, 0.31] 0.39 *** [0.24, 0.62]
Vaccination site
Other 146 (26.0) 71 (48.6) 42 (28.8) 33 (22.6) Ref Ref
Private clinic 415 (74.0) 171 (41.2) 114 (27.5) 130 (31.3) 0.61 * [0.38, 0.98] 0.69 [0.41, 1.16]
Insurance type
Other 230 (41.2) 108 (46.9) 57 (24.8) 65 (28.3) Ref Ref
Private 328 (58.8) 132 (40.2) 99 (30.2) 97 (29.6) 0.82 [0.55, 1.23] 1.16 [0.74, 1.83]
Regular healthcare provider
No 53 (9.4) 20 (37.7) 16 (30.2) 17 (32.1) Ref Ref
Yes 508 (90.6) 222 (43.7) 140 (27.6) 146 (28.7) 1.29 [0.66, 2.55] 1.02 [0.50, 2.10]
Ability to take time off work
No 132 (23.6) 54 (40.9) 44 (33.3) 34 (25.8) Ref Ref
Yes 428 (76.4) 188 (43.9) 111 (25.9) 129 (30.2) 0.92 [0.57, 1.49] 0.67 [0.40, 1.11]
Health Beliefs
Cancer from HPV infection problem
No 154 (27.5) 52 (33.7) 34 (22.1) 68 (44.2) Ref Ref
Yes 135 (24.1) 89 (65.9) 21(15.6) 25 (18.5) 4.66 *** [2.63, 8.25] 1.68 [0.83, 3.42)
Unsure 271 (48.4) 101 (37.3) 100 (36.9) 70 (25.8) 1.89 ** [1.18, 3.03] 2.86 ** [1.71, 4.77]
Perceived collective benefits of vaccines

4.16

± (0.96)

4.32

± (0.89)

4.06

± (0.96)

4.02

± (1.02)

1.40 ** [1.13, 1.74] 1.03 [0.83, 1.28]
Lack of confidence in vaccines

1.68

± (0.72)

1.51

± (0.61)

1.72

± (0.69)

1.88

± (0.83)

0.46 *** [0.34, 0.63] 0.77 [0.58, 1.03]
Perceived risks of vaccination

3.00

± (0.96)

2.88

± (1.00)

3.00

± (0.83)

3.21

± (0.99)

0.70 *** [0.56 0.87] 0.79* [0.63, 1.00]
Perceived vaccine importance

4.21

+ (0.78)

4.40

± (0.67)

4.16

± (0.69)

3.98

± (0.94)

2.05 *** [ 1.56, 2.72] 1.29 [0.99, 1.69]
Perceived benefits of HPV vaccines

3.80

± (0.90)

4.32

± (0.60)

3.75

± (0.64)

3.09

± (0.99)

9.34 *** [6.36, 13.72] 2.63 *** [1.90, 3.58]

Interpersonal

altruism

2.66

± (0.80)

2.78

± (0.81)

2.55

± (0.67)

2.57

± (0.73)

1.45 ** [1.11, 1.89] 0.97 [0.72, 1.3]

1Bolded values are significant at p < 0.05*, p < 0.01**, p < 0.001***